Vision Care Industry

Vision Screeners Market Analysis

The Vision Screeners Market is expected to register a CAGR of 5% during the forecast period.

• COVID-19 significantly impacted the vision screeners market since ophthalmic consultations and diagnosis were delayed due to the lockdown restrictions across the globe. For instance, according to an article published in August 2022 in MDPI journal, the lockdown during COVID-19 had a major impact on ophthalmic outpatient care in Riyadh as hundreds of appointments were canceled. This affected the course of the disease, which led to neglect of existing symptoms, a delay in detecting potentially sight-threatening complications, or even a delay in vision screening, all of which contributed to a worsening of visual outcomes.
• Thus, the utilization of vision screeners was limited during the pandemic, which impacted market growth. However, as the pandemic restrictions eased in the post-pandemic situation, the market recovery was led by an increase in vision screener device sales, new product launches, and increased eye diseases.
• The vision screener market is likely to grow during the forecast period due to the growing incidences of eye disorders, increased awareness about eye health, and technological advancements. Vision screeners are used in detecting several vision problems. They are useful for the treatment of eye-related disorders. The increasing rate of vision problems is common due to a lack of proper nutrition, irregular eye check-ups, inconsistent care, and prolonged screen time.
• For instance, as per the 2022 Vision Index report, research was conducted with myopia patients, with most respondents (81%) having trouble seeing objects at a distance and short-sightedness being the most common diagnosis for those who have had their eyesight examined by an optometrist (40%) in Australia in 2022. Increasing eye-related disorders and improved screening and diagnosis are projecting a significant impact on the market's growth. These factors lead to the widespread use of vision screeners for early indications and treatments, further boosting the market's growth.
• Furthermore, rising government initiatives and strategic activities by the key players, such as product launches, collaborations, and acquisitions, are expected to drive market expansion. For instance, according to the July 2021 update by the World Health Organization (WHO), governments adopted a new resolution at the UN general assembly pledging additional efforts to make eye care services a critical component of universal health coverage and address the growing impact of vision loss on sustainable development.
• Additionally, in August 2022, Thane-based Swaraashi Netralya introduced two state-of-the-art ophthalmic devices named "3nethra neo-HD FA" and "Mirante SLO/OCT to diagnose all ophthalmic medical conditions in children and adults in areas where medical help is the farthest away.
• Hence, due to the high prevalence of ophthalmic diseases, the rise in government initiatives to support eye care, and the increase in strategic product launches, the vision screeners market is likely to witness growth during the forecast period. However, the high cost of vision screener devices is expected to restrain market growth.

Vision Screeners Market Trends

Hospital Segment is Expected to Witness a Healthy Growth Over the Forecast Period

• The hospital segment is expected to witness healthy growth due to the increasing number of targeted ophthalmic patient pools in hospitals, growing awareness about the importance of early detection of eye diseases, and the emergence of multispecialty ophthalmic hospitals worldwide.
• For instance, according to the activity report published by Aravind Eyecare System Chennai, 4.3 million outpatient cases were reported in the hospital from April 2021 to March 2022. Thus owing to the high prevalence of patient pools in hospitals that undergoes eye examinations, the demand for vision screeners is likely to rise, contributing to the segment growth over the forecast period.
• Furthermore, an increase in investments to launch advanced eye care hospitals is expected to contribute to segment growth. For instance, in February 2023, a GBP 300 million (USD 393.5 million) contract was awarded to Bouygues UK to build Oriel, the new integrated UCL-Moorfields Eye Hospital Centre for advancing eye health. Moreover, new ophthalmic hospital launches, collaborations, and partnerships are major factors boosting the market growth.
• For instance, in December 2022, ASG Eye Hospitals, an eye hospital chain, launched its new hospital in Vashi, Navi Mumbai. The new super-specialty eye hospital is ASG's second facility in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra, India. Hence, these hospital expansions and launches are expected to create a significant demand for vision screeners, driving market growth.
• Additionally, hospital expansion and government collaboration in eye care are expected to promote market growth during the forecast period. For instance, in May 2022, Sankara Eye Hospital launched dedicated Centres of Excellence in vitreoretinal diseases and oncology and pediatric ophthalmology, strabismus, and neuro-ophthalmology in Bengaluru.
• Hence, due to the increase in the ophthalmic disease patient pool in hospital rise in ophthalmic hospital launches and expansions, the hospital segment is likely to witness significant growth during the forecast period.

North America is Expected to Witness a Significant Growth Over the Forecast Period

• North America is expected to witness significant market growth in the vision screeners market due to the rising burden of eye disorders, an increase in government initiatives to undergo vision screening, well-established healthcare infrastructure, and the presence of key market players.
• For instance, In addition, as per the data updated by the Centers for Disease Control and Prevention (CDC), in December 2022, approximately 12 million people of age 40 years and over in the United States have vision impairment, including 1 million who are blind, 3 million who have vision impairment after correction, and 8 million who have vision impairment due to uncorrected refractive error. The large population suffering from vision disorders necessitates proper eye examinations, which, thereby likely to drive the market in North America during the forecast period.
• Additionally, in October 2022, the Canadian Ophthalmological Society and the Canadian Association of Optometrists collaborated to conduct a joint access research survey in vision health. The survey revealed that Canadians experienced or have been diagnosed with one or more changes to their eye health which demanded a comprehensive exam and pointed to a significant need for eye disease awareness. Hence, such surveys are likely to create a demand for a proper eye examination, thereby boosting market growth over the forecast period.
• Furthermore, an increase in government initiatives and campaigns to undergo proper eye disease diagnosis and strategic product launches by the key players are expected to drive market growth.
• For instance, in January 2023, the Canadian Ophthalmological Society (COS) conducted the Glaucoma Awareness program, which recommended regular eye exams for difficult-to-detect eye disease among the Canadian Population. Moreover, in August 2021, Maryland-based RightEye launched eye care's first automated sensorimotor exam for binocular vision testing. RightEye Sensorimotor is a simple, all-in-one examination method that optometrists and ophthalmologists can use on every patient to objectively identify and treat binocular vision problems and oculomotor dysfunction.
• Hence, such awareness programs and advanced vision screeners launches are expected to augment the market growth in North America. Thus, due to the high prevalence of ophthalmic diseases, rise in awareness campaigns, and increase in vision screener launches, North America is expected to grow in the forecast period.

Vision Screeners Industry Overview

The vision screeners market is moderately fragmented in nature. Companies are focusing on new developments and advancements in vision screeners. This is expected to increase competition in the area further. Many companies are focused on mergers, acquisitions, and collaboration to expand their product availability across the studied region. Some major key players are Baxter International (Hill-Rom Holdings, Inc.), FIM Medical SAS, OCULUS Inc., Plusoptix Inc., Stereo Optical Co. Inc., Adaptica Srl, and Essilor Instruments USA, among others.

Vision Screeners Market Leaders

Vision Screeners Market News

• May 2023: The Public Health Protection Department of the Dubai Health Authority (DHA) completed a six-month-long vision-screening campaign in schools across Dubai. Over 26,700 students from various schools in Dubai participated in the basic vision tests (visual acuity) conducted by qualified optometrists from Al Jaber Optical's expertise team in collaboration with the DHA.
• March 2023: Visionix revealed its new multimodal screener device update with its second-generation VX 650. VX 650 is an advanced anterior segment analyzer with retinal imaging. The advanced wavefront-based aberrometer's "quick mode" and new capture flexibilities can significantly reduce the screening time by half, providing improved product efficiency.